Original Research

Combination of erlotinib and a PARP inhibitor inhibits growth of A2780 tumor xenografts due to increased autophagy

Sui H, Shi C, Yan Z, Li H

Drug Design, Development and Therapy 2015, 9:3183-3190

Published Date: 22 June 2015